Hanmi Pharm. Co., Ltd. (128940.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.79T |
| Enterprise Value | 6.12T |
| P/E Ratio | 26.19 |
| PEG Ratio | 0.35 |
| Price/Sales Ratio | 3.22 |
| Price/Book Ratio | 4.35 |
| Enterprise/Revenue | 3.4 |
| Enterprise/EBITDA | 17 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.14 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 1.55T |
| Revenue/Share | 107,709.51 |
| Gross Profit | 884.41B |
| EBITDA | 322.68B |
| Net Income | 170.48B |
| Diluted EPS | 13,362 |
Balance Sheet
| Total Cash | 297.92B |
| Total Cash/Share | 20,708.86 |
| Total Debt | 418.36B |
| Total Debt/Equity | 0.32 |
| Current Ratio | 1.54 |
| Book Value Per Share | 102,792.89 |
Price History
| 52-Week Change | 29.49 |
| 52-Week High | 647,000 |
| 52-Week Low | 267,500 |
| Moving Average 50 Days | 465,000 |
| Moving Average 200 Days | 455,322.5 |
Statistics
| Average Volume | 130,680 |
| Shares Outstanding | 12.68M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2,250 |
| Trailing Annual Dividend Yield | 0.57 |
| Payout Ratio | 0.08 |
| Last Split Factor | 51:50 |
| Last Split Date | December 27, 2023 |
AD
